This announcement is a separate document:
開拓藥業-B：自願公告 福瑞他恩治療男性脫髮美國II期臨床試驗完成患者入組
KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLMENT IN PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF MALE AGA PATIENTS IN THE US
Aug 3, 2022 18:50
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.